
Adjuvant activity can be greatly improved by appropriate formulation of cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs).
Lucille Gagliardo is a technician IV, James A. Baker Institute for Animal Health, Cornell University
Adjuvant activity can be greatly improved by appropriate formulation of cytosine-phosphorothioate-guanine oligodeoxynucleotides (CpG ODNs).
Published: October 2nd 2010 | Updated: